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THE THERAPEUTIC ALLIANCE OVER 10 
SESSIONS OF THERAPY FOR BORDERLINE 
PERSONALITY DISORDER: AGREEMENT AND 
CONGRUENCE ANALYSIS AND RELATION TO 
OUTCOME
Yogev Kivity, PhD, Kenneth N. Levy, PhD, Stéphane Kolly, MD,  
and Ueli Kramer, PhD
The authors examined whether alliance dynamics are affected by tailoring 
the therapeutic relationship to the individual patient in brief psychotherapy 
of borderline personality disorder. Sixty patients were randomized to 
10-session Good Psychiatric Management (GPM-BV) or GPM combined 
with Motive-Oriented Therapeutic Relationship techniques (MOTR+GPM-
BV). Patient- and therapist-rated alliance was assessed weekly. Self-re-
ported symptomatic distress was assessed pre-, mid-, and posttreatment. 
In MOTR+GPM-BV, stronger therapist-rated alliance predicted lower 
symptomatic distress in the same timepoint, but not in a lag, whereas 
symptomatic distress predicted therapist-rated alliance in a lag. Therapist-
rated alliance was lower than patient-rated alliance in GPM-BV but not in 
MOTR+GPM-BV. In MOTR+GPM-BV, higher agreement on strong alli-
ance tended to predict lower symptomatic distress. Patient- and therapist-
rated alliances were temporally congruent, but congruence did not predict 
outcome. Addressing the relationship needs of patients may partly exert its 
salutary effect by increasing agreement between patients’ and therapists’ 
experience of the alliance.
Keywords: therapeutic alliance, borderline personality disorder, good 
psychiatric management, motive oriented therapeutic relationship, plan 
analysis
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Borderline personality disorder (BPD) is a severe and prevalent disorder 
characterized by instability in interpersonal relationships as well as emotion 
dysregulation and impulsivity (Skodol et al., 2002). A number of efficacious 
treatments for BPD exist (e.g., Bateman & Fonagy, 1999; Clarkin, Levy, Len-
zenweger, & Kernberg, 2007; Gunderson & Links, 2008; Linehan, Arm-
strong, Suarez, Allmon, & Heard, 1991), but their mechanisms of change 
remain poorly understood.
One of the hallmark features of BPD is unstable and tumultuous rela-
tionships that tend to vacillate between idealization and devaluation (Ameri-
can Psychiatric Association, 2013). As clinicians and researchers have noted, 
the difficulties in interpersonal relations of these patients pose challenges in 
building a strong therapeutic alliance with BPD patients (e.g., Gabbard et 
al., 1988; Yeomans et al., 1994). These difficulties may explain the fluctua-
tions in the alliance with BPD patients (Levy, Beeney, Wasserman, & Clar-
kin, 2010) and may undermine the utility of the therapeutic alliance, which 
is known to be a robust predictor of good treatment outcome (Horvath, 
Del Re, Flückiger, & Symonds, 2011). Indeed, a recent meta-analysis (Levy, 
Scala, & Ellison, 2017) found that the alliance–outcome correlation in treat-
ments of BPD was weak (r = .12), and significantly smaller than the moderate 
correlation reported in the most up-to-date meta-analysis of the alliance–
outcome correlation (Horvath et al., 2011).
One possible way to mitigate the difficulties of forming a therapeutic al-
liance with patients with BPD is by increasing the responsiveness to their re-
lationship needs using individualized treatment plans. Indeed, a recent study 
(Kramer, Kolly, et al., 2014) examined the utility of using an ingredient of 
treatment individualization, called the motive-oriented therapeutic relation-
ship (MOTR) method (Caspar, 2007), for treatment outcome. MOTR is 
based on the principles of Plan Analysis (PA), an integrative case concep-
tualization that includes hierarchical structure of inferred goals and means 
that underlie the patient’s interpersonal or intrapsychic behaviors and expe-
riences (Caspar, 2007; Grawe, 1980). MOTR assumes that if a therapist ad-
dresses the patient’s underlying goals within the limits of the therapeutic re-
lationship, it is no longer necessary for the patient to use problematic means 
to attain personal goals (Caspar, 2007). Because each patient is assumed to 
be guided by different hypothetical Plans, the therapeutic relationship offer 
must be constructed differently for each patient, in a fundamentally idio-
graphic and thus responsive manner (Caspar, 2007; Kramer & Stiles, 2015). 
Theoretically, these adaptations could help overcome some of the difficulties 
in alliance in the treatment of BPD by creating a more stable alliance. In ad-
dition, negotiating and addressing the therapeutic alliance should result in 
increased agreement between therapists and patients on the alliance and in 
better ability to capitalize on the alliance to promote better outcomes.
Kramer and colleagues (Kramer, Flückiger, et al., 2014; Kramer, Kolly, 
et al., 2014) examined the effects of adding MOTR to a 10-session, brief 
version of Good Psychiatric Management for BPD (GPM-BV; Gunderson & 
Links, 2008). GPM is a psychiatric and psychotherapeutic approach based 
on an attachment-informed etiological model of BPD that includes compo-
nents such as establishment of psychiatric diagnosis, goal setting, motiva-
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tion enhancement, and relational interpretations of core conflictual themes. 
Kramer and colleagues (Kramer, Flückiger, et al., 2014; Kramer, Kolly, et al., 
2014) found that MOTR+GPM-BV resulted in greater changes in symptom-
atic distress, the primary outcome measure in the study. In addition, both 
treatments were efficacious in general and led to similar changes in BPD-
specific symptoms. 
Given the presumably central role of the alliance in MOTR, Kramer and 
colleagues (Kramer, Flückiger, et al., 2014; Kramer, Kolly, et al., 2014) also 
conducted preliminary examinations of alliance ratings and their relations to 
outcome. It was found that therapist-rated (but not patient-rated) alliance 
tended to increase more rapidly in MOTR+GPM-BV compared to GPM-BV, 
while there were no differences between treatments in average levels (across 
sessions) of the alliance (Kramer, Kolly, et al., 2014). Kramer, Flückiger, et al. 
(2014) also examined the correlations between alliance ratings in each of the 
10 sessions of treatment and overall change in symptomatic distress. On av-
erage across the 10 sessions, stronger patient-rated alliance predicted better 
outcome in MOTR+GPM-BV but not in GPM-BV, while, on the contrary, 
weaker therapist-rated alliance predicted better outcome in MOTR+GPM-
BV but not in GPM-BV (Kramer, Flückiger, et al., 2014).
Thus, these preliminary results show that MOTR+GPM-BV is related 
to better outcome, but it is still unclear what drives this effect and how it is 
related to the therapeutic alliance. In addition, these studies examined the 
associations between alliance and outcome using zero-order correlations on 
all available data, without taking into consideration the multilevel structure 
of the data and without handling missing data. Thus, the present study aims 
to examine the dynamics of the therapeutic alliance in the Kramer and col-
leagues studies (Kramer, Flückiger, et al., 2014; Kramer, Kolly, et al., 2014). 
In addition, by utilizing multilevel modeling on imputed data, the present 
study is expected to increase the power of the analyses and result in more 
accurate understanding of the dynamic and longitudinal association between 
alliance and outcome (Enders, Mistler, & Keller, 2016). These data-analytic 
approaches may provide a more nuanced understanding of the role of the 
alliance in MOTR+GPM-BV, and in early phases of treatments of BPD in 
general.
As mentioned above, Kramer, Flückiger, et al. (2014) found that 
MOTR+GPM-BV resulted in more rapid increases in therapist-rated alli-
ance with no differences in average levels of the alliance. This suggests that 
changes in therapist-rated alliance may be more strongly related to outcome 
in MOTR+GPM-BV than the average strength of the alliance per se. Some 
studies used repeated measurements of the alliance to disentangle the within- 
and between-patient variability in the alliance and it relation to outcome (re-
viewed in Zilcha-Mano, 2017). The within-patient variability in alliance rat-
ings (henceforth session-level alliance) is a “state-like” measure that captures 
the fluctuations of the alliance for a given patient during therapy, whereas 
the between-patient variability in alliance ratings (henceforth patient-level 
alliance) is a “trait-like” measure that captures the average level of the alli-
ance for a given patient during therapy. These studies found that session-lev-
el alliance is generally related to outcome (reviewed in Zilcha-Mano, 2017), 
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which is consistent with the findings in the studies by Kramer and colleagues 
(Kramer, Flückiger, et al., 2014; Kramer, Kolly, et al., 2014), although a di-
rect examination of this possibility in the Kramer and colleagues’ (Kramer, 
Flückiger, et al., 2014; Kramer, Kolly, et al., 2014) dataset is still needed. 
In addition, the finding that patient- and therapist-rated alliances were 
differentially associated with outcome emphasizes the importance of exam-
ining the degree of correspondence between these two perspectives, and the 
way it differs by treatment. Recent studies have begun to examine this cor-
respondence by focusing on two different aspects of correspondence: the 
temporal covariation of patient- and therapist-rated alliance (“temporal con-
gruence”) and the absolute differences between these ratings within specific 
sessions (“disagreement”) and the way they predict outcome (Atzil-Slonim 
et al., 2015; Compare, Tasca, Lo Coco, & Kivlighan, 2016; Marmarosh 
& Kivlighan, 2012; Zilcha-Mano, Snyder, & Silberschatz, 2017). In these 
studies, therapists tended to rate the alliance as weaker than their patients, 
while conflicting findings exist regarding the degree of temporal congruence 
between patient and therapist with some studies reporting a positive correla-
tion between patient- and therapist-rated alliance over time and some stud-
ies failing to find such a correlation (also reviewed in Tryon, Blackwell, & 
Hammel, 2007). Also, it is still unclear whether agreement and congruence 
predict outcome, and if so, whether the session-level or patient-level compo-
nent of these measures is more predictive. Existing studies so far have not 
examined differences in agreement and congruence between different types 
of treatments, which could possibly explain their conflicting findings.
In sum, the present study examines session- and patient-level alliance 
and the correspondence between patient- and therapist-rated alliance in brief 
treatments of BPD, and the way these are related to outcome. We had the fol-
lowing hypotheses. (a) Given previous findings (Kramer, Kolly, et al., 2014), 
we expected session-level alliance to predict outcome in MOTR+GPM-BV 
but not in GPM-BV. To better control for temporality, we examined predic-
tion of outcome at the same, as well as subsequent, timepoints. We did not 
expect patient-level alliance to predict outcome. (b) Based on previous find-
ings (Atzil-Slonim et al., 2015; Compare et al., 2016), we expected therapists 
to rate the alliance as weaker than patients (“directional disagreement”). 
Given the explicit focus on responsiveness in MOTR, we expected the degree 
of agreement to be higher in MOTR+GPM-BV compared to GPM-BV. We 
did not have a strong hypothesis regarding the mean temporal congruence of 
patient and therapist ratings across treatment types because of the conflict-
ing findings in the literature. However, we did expect the degree of temporal 
congruence to be higher in MOTR+GPM-BV compared to GPM-BV because 
of the focus on responsiveness in this treatment. (c) We examined the asso-
ciation of agreement and congruence with treatment outcome without strong 
hypotheses regarding the nature of these associations because of the mixed 
findings in the literature (Atzil-Slonim et al., 2015; Compare et al., 2016; 
Marmarosh & Kivlighan, 2012; Zilcha-Mano et al., 2017).
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METHOD
PARTICIPANTS
Participants were outpatients at a European French-speaking university psy-
chiatry clinic who met DSM-IV-TR criteria for BPD (American Psychiatric 
Association, 2000). In the original study, 85 patients were randomized but 
11 patients discontinued after the first treatment session (before MOTR was 
introduced), and therefore were not included in analyses. Out of the 74 pa-
tients who were included in the original intent-to-treat analyses, 60 patients 
had at least one report of the alliance and were included in the present study. 
Out of these, two MOTR+GPM-BV and two GPM-BV patients dropped out 
during treatment but were still included in analyses. The final sample con-
sisted of 32 MOTR+GPM-BV patients (17 females, age 20–55, M = 35.31, 
SD = 9.89), and 28 GPM-BV patients (23 females, age 20–55, M = 31.43, 
SD = 9.19). The distribution of family status was: single (MOTR+GPM-BV 
= 25%, GPM-BV = 54%), married (MOTR+GPM-BV = 47%, GPM-BV = 
21%), divorced/separated (MOTR+GPM-BV = 28%, GPM-BV = 25%). No 
group differences emerged in the rate of dropout and in age, but the GPM-
BV group had significantly more females and single patients, and fewer mar-
ried patients. 
TREATMENTS AND THERAPISTS
Twenty-two therapists were randomized to treatment condition (ITT sample: 
GPM-BV, n = 13; MOTR+GPM-BV, n = 9). GPM-BV therapists treated 1–11 
patients (M = 2.9), and MOTR+GPM-BV therapists treated 1–14 patients 
(M = 4). Therapists were psychiatrists/psychologists (n = 19) and nurses (n = 
3) with at least a basic psychodynamic training and an average of 2.5 years 
of residency. Therapists were trained in GPM-BV at the outset of the study 
and were supervised during the entire study. MOTR+GPM-BV therapists 
were trained and supervised by the model developer and an expert in this 
approach. Therapists received individual supervision twice over the course 
of each treatment (after Session 1 and at midtreatment).
GPM-BV. This brief version of GPM included a psychiatric and psycho-
therapeutic approach based on an attachment-informed etiological model of 
BPD (see Gunderson & Links, 2008). A specific manual was elaborated to 
adapt the treatment principles to 10 weekly sessions (Kolly et al., 2010) that 
included: (a) establishment of psychiatric diagnoses and communication of 
them to the patient, (b) psychiatric history taking, (c) identification of main 
problems and establishment of treatment focus, (d) definition of short-term 
objectives and general enhancement of motivation, (e) dealing with treat-
ment-interfering problems, and (f) formulation of relational interpretations 
of core conflictual themes. 
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MOTR+GPM-BV. This treatment included, in addition to the GPM-BV in-
tervention, formulating a PA and use of MOTR techniques when indicated 
(Caspar, 2007). PA is an integrative case conceptualization method with 
ensuing relational techniques (MOTR). In PA, the therapist makes infer-
ences about the patient’s implied underlying needs based on his or her verbal 
and nonverbal behavior. Based on PA, the therapist defines and implements 
relational techniques (MOTR) in order to address the patient’s needs and 
motives within the limits of the therapeutic relationship, without reinforc-
ing problematic behaviors or experiences. The intake session provided the 
therapist with information for the establishment of the PA and the ensuing 
MOTR, which were implemented in Sessions 2–10.
As reported by Kramer, Kolly, et al. (2014), there was excellent adherence 
to GPM-BV principles for both GPM-BV (GPM adherence scale: M = 4.32; 
SD = .37) and MOTR+GPM-BV (M = 4.37; SD = .26), which did not differ 
by condition (p = .57). Adherence to MOTR was higher in MOTR+GPM-BV 
(PA and MOTR ratings; M = 1.55; SD = .44) than in GPM-BV (M = .48; SD 
= .39; p < .01).
MEASURES
Working Alliance Inventory–Short Form. The French version (Corbière, 
Bisson, Lauzon, & Ricard, 2006) of this 12-item questionnaire (Tracey & 
Kokotovic, 1989) was used to assess patient- (WAI-P) and therapist-rated 
(WAI-T) alliance on a 1 (never) to 7 (always) scale (e.g., “I feel that my 
therapist appreciates me”). Questionnaires were completed after each ses-
sion, and total scores were used for analyses. Multilevel internal consistency 
coefficients (Shrout & Lane, 2012) in the current study were α = .99 for both 
WAI-P and WAI-T.
Outcome Questionnaire-45.2 (OQ-45). This 45-item self-report question-
naire (Lambert et al., 2004) was used to assess symptomatic distress on a 0 
(never) to 4 (always) scale (e.g., “I feel stressed at work/school”) during the 
past week, including the day of the assessment. Questionnaires were com-
pleted at pre-, mid-, and posttreatment, and total scores were used for analy-
ses. Multilevel internal consistency in the current study was α = .98. We fo-
cused on this measure of all outcome measures collected in the study because 
this was the primary outcome measure in the original study.
DATA PREPARATION AND DATA-ANALYTIC APPROACH
All data analyses were implemented in R version 3.3.2 (R Core Team, 2016).
Missing Data Imputation. Out of the possible 600 session-by-session time-
points in the study (60 patients × 10 sessions), 195 timepoints had missing 
data in at least one of the study variables (149–188 within measures). Out 
of the possible 180 OQ-45 measurement timepoints in the study (60 patients 
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× 3 measurements), 33 timepoints had missing data. Because these data can-
not be assumed to be missing completely at random, we employed multilevel 
multiple imputation by chained equations (van Buuren & Groothuis-Oud-
shoorn, 2011) to arrive at a complete dataset and reduce possible biases in 
random slopes models due to nonresponse (Enders et al., 2016). Data were 
imputed using package “mice” (van Buuren & Groothuis-Oudshoorn, 2011) 
with 20 imputations and 20 iterations for each imputation. Patient-level 
predictors included clinical and demographic variables at intake, dropout 
status, and treatment type. Time-level predictors included session number 
and all outcome and process variables in the study. Postimputation diag-
nostics suggested that the imputation solution achieved good results. Thus, 
600 timepoints were included in analyses of session-by-session variables, and 
180 timepoints were included in analyses involving the OQ-45. Subsequent 
analyses were run repeatedly on all copies of the data and then pooled to ar-
rive at the final estimates.
Changes in Alliance During Treatment. We first attempted to replicate the 
analyses in the Kramer, Kolly, et al. study (2014) regarding differences be-
tween treatments in change in alliance. Given the hierarchical nature of our 
data (assessments repeated within patients), data were analyzed using linear 
multilevel models in package “nlme” (Pinheiro, Bates, DebRoy, Sarkar, & 
R Core Team, 2016). Analyses were adjusted for repeated measures with 
restricted maximum likelihood estimation method and random intercepts 
and slopes at the patient level. In addition, a first-order autoregressive cova-
riance structure [AR(1)] was modeled at Level 1. AR(1) was chosen in order 
to account for auto-regression in the dependent variable and at the same 
time avoid a possible bias due to inclusion of the lagged dependent variable 
as a predictor in the model (see Falkenström, Finkel, Sandell, Rubel, & Hol-
mqvist, 2017, for a detailed discussion). Session number was included as a 
Level 1 predictor while treatment type was included as a Level 2 predictor. 
Session number was centered around the first session, so intercepts represent 
the alliance score at the beginning of treatment, while slopes represent the 
average change in alliance between sessions.1 
Disaggregation of Session- and Patient-Level Alliance. We decomposed ses-
sion- and patient-level alliance following procedures recommended by Wang 
and Maxwell (2015). This approach allows us to disentangle trait-like from 
state-like components of the alliance by looking at the variability in alli-
ance scores at the within- and between-patient levels. Mean alliance scores 
for a given patient served as patient-level scores (centered around the grand 
1.  We also utilized longitudinal cluster analysis to examine how patients cluster in their patterns of alli-
ance development. We found two different clusters of linear development that differed only in the baseline 
level and rate of growth, but not in the shape of the trajectory of change. These findings are not reported 
here due to space limitations and because they did not contribute to the understanding of the development 
of the alliance beyond what was already revealed by the multilevel models. Full details are available upon 
request from the first author. 
8 KIVITY ET AL.
mean), whereas session-by-session scores served as session-level scores (cen-
tered around the individual patient mean).2 
To better understand the temporal sequence of these relationships, we 
examined how alliance predicts symptomatic distress in the same as well as 
in subsequent timepoints (with a lag of one timepoint) and also how outcome 
predicts alliance in subsequent timepoints (with a lag of one timepoint).3 The 
session-level effect represents the session-by-session association between the 
alliance and outcome, while the patient-level effect represents the associa-
tion between the global strength of the alliance (i.e., across sessions) and 
mean levels of outcome. Consistent with the Wang and Maxwell approach 
(2015), we did not control for time effects in our data because time effects 
are considered an inherent part of the alliance–outcome correlation (i.e., al-
liance and outcome simultaneously improve during treatment; for a similar 
argument see Falkenström et al., 2017). We also included treatment type as 
a Level 2 predictor and its interactions with the within- and between-patient 
effects in order to examine group differences in these effects. Separate models 
were fitted to patient- and therapist-rated alliance scores.
Agreement and Congruence in Alliance Scores. To examine whether thera-
pists’ alliance shows agreement and congruence with patients’ ratings, we 
adopted West and Kenny’s (2011) Truth & Bias Model. We first centered 
both patient- and therapist-rated alliance scores around the individual pa-
tient-rated alliance. Then, we fitted a two-level model (sessions repeated 
within patients) in which therapist-rated alliance was predicted from patient-
rated alliance. The estimated intercept represents the directional disagree-
ment, with negative values suggesting lower therapists’ ratings compared 
to patients’ ratings. The estimated slope coefficient of patient-rated alliance 
represents the degree of temporal congruence between patient and therapist 
ratings over time. To examine differences between treatments in agreement 
and congruence, we also included treatment type as a Level 2 predictor and 
its interactions with agreement/congruence scores.
To examine session- and patient-level agreement as predictors of out-
come, we fitted multilevel polynomial regression models (Kivlighan, Kline, 
Gelso, & Hill, 2017; Shanock, Baran, Gentry, Pattison, & Heggestad, 2010) 
2. The OQ-45 measures symptoms during the past week, including the day of the assessment, while the 
WAI measures current alliance. Thus, it would have been preferable to predict symptoms from alliance 
in the previous session to test for “simultaneous prediction.” However, the OQ-45 was administered 
only at Sessions 1, 5, and 10, which means that the Session 1 OQ-45 would not have a WAI to match, 
thus removing a third of the observations (and even two thirds in cross-lagged models) and would have 
significantly underpowered the analyses. Given that the OQ-45 also takes into account symptom severity 
during the day of the assessment, we felt that using the WAI from the same session was preferable in the 
current study. 
3. We also examined whether alliance ratings predict weekly self-esteem as measured by the self-esteem 
subscale of the Bern Post-Session Report. We focused on this specific subscale because it was the only 
subscale to show significant change during treatment and it was the focus of the original study (Kramer 
et al., 2014a). The results showed that therapist- and patient-rated alliance predicted same-session self-
esteem in both groups. No cross-lagged effects emerged. These findings are not reported in full here due 
to self-esteem being of secondary interest and due to space limitations. Full details about these analyses 
are available upon request from the first author.
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separately for each group, with OQ-45 as the dependent variable and the fol-
lowing predictors at each level (session and patients): WAI-P, WAI-T, WAI-
P2, WAI-P×WAI-T, and WAI-T2. All WAI variables were centered to the scale 
midpoint before inclusion in the model. We then used the estimates to calcu-
late slopes and curvatures along the lines of agreement and disagreement and 
to plot response surfaces. The following estimates were examined: The slope 
along the line of agreement tests whether symptom severity is lower when 
therapist and patient agree that the alliance is strong compared to when they 
agree that it is weak. The curvature along the line of agreement tests whether 
the effect of agreement changes as a function of alliance strength (e.g., if 
agreement is more important for weak alliances than for strong ones). The 
curvature along the line of disagreement tests whether disagreement between 
patient and therapist predicts higher symptom severity. The slope along the 
line of disagreement tests the direction of the effect of disagreement (e.g., 
whether symptom severity is lower when patient-rated alliance is higher than 
therapist-rated alliance, or the other way around).
To examine patient-level temporal congruence as a predictor of out-
come, we computed a correlation between patient- and therapist-rated alli-
ance across sessions separately for each patient. We then used those correla-
tions (Fisher’s z-transformed and grand-mean centered) as Level 2 predictors 
of OQ-45. To examine differences between treatments in the effect of con-
gruence on symptom severity, we also included treatment type as a Level 2 
predictor and its interactions with congruence scores.
Throughout the article, effect sizes are calculated from t values and dfs 
from multilevel models (cf. Crits-Christoph et al., 2009) and are presented 
in Cohen’s d metric.
FIGURE 1. Change in alliance ratings during Good Psychiatric 
Management, brief-version (GPM-BV; top panel) and GPM com-
bined with Motive-Oriented Therapeutic Relationship techniques 
(MOTR+GPM-BV; bottom panel). Solid lines represent patient-rated 
alliance scores, and dashed lines represent therapist-rated alliance 
scores. A significant increase in patient-rated alliance was observed 
in MOTR+GPM-BV but not in GPM-BV. A significant increase in 
therapist-rated alliance was observed in both treatments.
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RESULTS
CHANGES IN ALLIANCE DURING TREATMENT
Figure 1 presents changes in patient- and therapist-rated alliance during 
MOTR+GPM-BV and GPM-BV. As the figure shows, therapist-rated alli-
ance at baseline could be characterized as weak-moderate (estimated means: 
MOTR+GPM-BV = 45.57; GPM-BV = 47.25) and did not differ by group 
(t225 = .90, p = .35, d = .12). In addition, therapist-rated alliance increased 
during both MOTR+GPM-BV (b = 1.88, t73 = 4.61, p < .01, d = 1.08) and 
GPM-BV (b = 1.04, t180 = 2.78, p < .01, d = .41), without group differences 
in rates of increase (t99 = 1.50, p = .14, d = .30).
As Figure 1 shows, patient-rated alliance at baseline could be character-
ized as moderate (estimated means: MOTR+GPM-BV = 53.38; GPM-BV = 
58.75) and did not differ by group (t452 = 1.54, p = .12, d = .14). In addition, 
while patient-rated alliance increased during MOTR+GPM-BV (b = .76, t88 = 
2.09, p = .04, d = .45), it did not change during GPM-BV (b = .24, t110 = .65, 
p = .52, d = .12), although the group difference did not reach significance (t94 
= .99, p = .33, d = .20).
SESSION- AND PATIENT-LEVEL ALLIANCE TO PREDICT TREATMENT 
OUTCOME (HYPOTHESIS 1)
Estimated multilevel coefficients for the prediction of symptomatic distress 
from alliance ratings are presented in Table 1.
Prediction of Outcome in the Same Timepoint From Therapist-Rated Al-
liance. As Table 1 shows, we found that, consistent with hypotheses, ses-
sion-level alliance predicted symptomatic distress in the same timepoint in 
MOTR+GPM-BV (t70 = −2.81, p < .01, d = .67), but not in GPM-BV (t49 
= −1.41, p = .16, d = .40), although the difference between groups did not 
reach significance (t58 = −.36, p = .72, d = .09). Thus, stronger therapist-rated 
alliance in a given timepoint predicted lower symptomatic distress in the 
same timepoint among patients receiving MOTR+GPM-BV but not among 
patients receiving GPM-BV. As we hypothesized, patient-level alliance did 
not predict symptomatic distress in MOTR+GPM-BV (t83 = −1.20, p = .23, 
d = .26) or in GPM-BV (t100 = −.75, p = .45, d = .15). Therefore, the mean 
therapist-rated alliance for a given patient was not associated with symptom-
atic distress.
Prediction of Outcome in the Same Timepoint From Patient-Rated Alliance. 
As Table 1 shows, contrary to our hypotheses, session-level alliance did not 
predict symptomatic distress in the same timepoint in MOTR+GPM-BV (t44 
= −1.15, p = .25, d = .35) or in GPM-BV (t56 = −.50, p = .62, d = .13). In addi-
tion, as we hypothesized, patient-level alliance did not predict symptomatic 
distress in MOTR+GPM-BV (t107 = −1.27, p = .25, d = .24) or in GPM-BV 
(t90 = −1.18, p = .27, d = .25).
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Cross-Lagged Relationships Between Outcome and Therapist-Rated Al-
liance. Contrary to our hypotheses, as shown in Table 1, session-level al-
liance did not predict symptomatic distress in subsequent timepoints in 
MOTR+GPM-BV (t30 = −1.21, p = .24, d = .44) or in GPM-BV (t25 = .04, 
p = .97, d = .02). However, session-level symptomatic distress predicted 
therapist-rated alliance in subsequent timepoints in MOTR+GPM-BV (t22 = 
−2.41, p = .02, d = 1.03) but not in GPM-BV (t34 = −.67, p = .51, d = .23). 
Thus, only in MOTR+GPM-BV did lower symptomatic distress in a given 
timepoint predict stronger therapist-rated alliance at subsequent timepoints.
Prediction of Outcome in Subsequent Timepoints From Patient-Rated Al-
liance. As shown in Table 1, contrary to our hypotheses, session-level al-
liance did not predict symptomatic distress in subsequent timepoints in 
MOTR+GPM-BV (t27 = −.01, p = .99, d = .00) or in GPM-BV (t26 = .03, p = 
.97, d = .01). In addition, session-level symptomatic distress did not predict 
patient-rated alliance in subsequent timepoints in MOTR+GPM-BV (t29 = 
−.16, p = .88, d = .06) or in GPM-BV (t26 = .02, p = .99, d = .01)
AGREEMENT AND CONGRUENCE IN ALLIANCE SCORES AND THEIR 
ASSOCIATION WITH TREATMENT OUTCOME (HYPOTHESES 2 AND 3)
Agreement. Estimated mean directional disagreement in MOTR+GPM-BV 
and GPM-BV and its association with treatment outcome are presented in 
Table 2. As the table shows, consistent with our hypotheses, we found that 
GPM-BV therapists had a negative disagreement with their patients (t394 = 
−2.92, p < .01, d = .29), while MOTR+GPM-BV therapists did not (t455 = 
−1.56, p = .12, d = .15), even though the difference in agreement between 
treatments did not reach significance (t395 = 1.08, p = .28, d = .11). Thus, 
GPM-BV therapists rated the alliance as consistently lower than their pa-
tients, while MOTR+GPM-BV therapists did not.
TABLE 1. Estimated Multilevel Regression Coefficients and 95% Confidence Intervals for the Simultaneous and Cross-
Lagged Prediction of Symptoms From Alliance and Cross-Lagged Prediction of Alliance From Symptoms
Therapist-Rated Alliance (Model a) Patient-Rated Alliance (Model b)
Model MOTR+GPM-BV GPM-BV MOTR+GPM-BV GPM-BV
Alliance predicting symptoms (simultaneous)
Session-level alliance −.67 [−1.15, −.20]** −.52 [−1.25, .22] −.50 [−1.37, .37] −.20 [−1.01, .60]
Patient-level alliance −.50 [−1.33, .33] −.35 [−1.27, .57] −.42 [−1.07, .24] −.39 [−1.03, .26]
Alliance predicting symptoms (cross-lagged)
Session-level alliance −.47 [−1.26, .32] .02 [−1.11, 1.16] −.01 [−1.31, 1.30] .02 [−1.31, 1.35]
Patient-level alliance −.42 [−1.34, .49] −.31 [−1.37, .75] −.46 [−1.18, .26] −.56 [−1.31, .19]
Symptoms predicting alliance (cross-lagged)
Session-level symptoms −.28 [−.53, −.04]* −.07 [−.27, .13] −.02 [−.23, .20] .00 [−.22, .23]
Patient-level symptoms −.13 [−.32, .06] −.12 [−.33, .09] −.10 [−.33, .12] −.10 [−.34, .14]
Note. MOTR = Motive-Oriented Therapeutic Relationship; GPM-BV = Good Psychiatric Management, brief-version. 
Symptomatic distress was measured by the Outcome Questionnaire–45.2; Therapist- and patient-rated alliance ratings 
were analyzed in separate models. */** significantly different from zero at the p < .05/.01 level.
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Results of the multilevel polynomial regression analysis to examine the 
association between agreement and symptomatic distress are presented in 
Table 2, and the respective response surfaces are plotted in Figure 2. The 
results showed a trend for session-level agreement to predict symptomatic 
distress in MOTR+GPM-BV (t90 = −1.91, p = .059) but not in GPM-BV (t78 = 
−1.22, p = .22). Thus, only in MOTR+GPM-BV, in sessions in which thera-
pists and patients agreed more on a strong alliance, did patients also tend to 
report lower symptomatic distress. The curvilinear effect of agreement was 
not significant in either MOTR+GPM-BV (t90 = 1.55, p = .12) or GPM-BV 
(t78 = .96, p = .34), which means that the effect of agreement was the same 
regardless of how strong the alliance was. This effect is also evident in Figure 
2, which shows that in MOTR+GPM-BV at the session level, the slope above 
the line of perfect agreement (WAI-T = WAI-P) is linear and negative. In 
other words, in MOTR+GPM-BV, greater session-level agreement on strong 
alliance tends to predict lower session-level symptomatic distress regardless 
of whether the alliance is high or low in that session. None of the other mea-
sures of agreement and disagreement had significant effects on symptomatic 
distress (ps = .11–.97).
Temporal Congruence. Estimated mean temporal congruence in 
MOTR+GPM-BV and GPM-BV is presented in Table 2. As the table shows, 
we found that positive congruence existed in both MOTR+GPM-BV (t205 = 
2.35, p = .02, d = .33) and GPM-BV (t218 = 2.23, p = .03, d = .30). However, 
contrary to our hypotheses, there were no differences between treatments in 
the degree of congruence (t232 = −.09, p = .93, d = .01). Therefore, in sessions 
TABLE 2. Estimated Mean Levels of Disagreement and Temporal Congruence Scores by Treatment 
Type From Truth and Bias Analysis (Top Panel) and Multilevel Polynomial Regression Coefficients for 
the Association of Session- and Patient-Level Disagreement Symptomatic Distress (Bottom Panel)
MOTR+GPM-BV GPM-BV
Truth and bias model
Mean disagreement −3.96 [−8.95, 1.03] −8.06 [−13.49, −2.63]**
Mean level of temporal congruence .25 [.04, .45]* .26 [.03, .49]*
Multilevel polynomial regression analysis
Session-level estimates
Slope along line of agreement −3.39 [−6.92, .14]† −1.29 [−3.40, .81]
Curvature along line agreement .10 [−.03, .23] .05 [−.05, .15]
Slope along line of disagreement −.30 [−3.03, 2.42] .61 [−1.39, 2.61]
Curvature along line disagreement .10 [−.05, .25] .05 [−.06, .16]
Patient-level estimates
Slope along line of agreement 1.33 [−3.45, 6.11] .30. [−2.33, 2.93]
Curvature along line agreement −.02 [−.24, .20] .13 [−.03, 0.29]
Slope along line of disagreement .05 [−3.02, 3.12] −.73 [−3.73, 2.26]
Curvature along line disagreement −.03 [−.27, .20] .14 [−.09, .36]
Note. MOTR = Motive-Oriented Therapeutic Relationship; GPM-BV = Good Psychiatric Management, brief-version. 
Numbers in brackets represent 95% confidence intervals. Negative disagreement scores indicate that therapist-rated 
alliance ratings were lower than those of their patients. Positive temporal congruence indicates positive association be-
tween therapist- and patient-rated alliance over time. †/*/** significantly different from zero at the p < .06/.05/.01 level.
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in which therapists rated the alliance as relatively strong, their patients were 
also likely to rate the alliance as strong, regardless of treatment type.
Looking at how patient-level congruence predicts symptomatic dis-
tress, we found that congruence did not predict symptomatic distress in 
MOTR+GPM-BV (b = .30, t108 = .12, p = .91, d = .02) or in GPM-BV (b = 
1.44, t109 = .89, p = .38, d = .17), with no differences between treatments (b = 
−1.14, t109 = -.38, p = .70, d = .07). Therefore, patient-level temporal covaria-
tion in alliance between therapist and patient did not predict symptomatic 
distress.
DISCUSSION
The present study examined the role that the dynamics and synchrony of pa-
tient and therapist ratings of the alliance play in the effect of adding MOTR 
to GPM-BV for BPD. We found that increases in patient-rated alliance oc-
curred in MOTR+GPM-BV but not in GPM-BV, while therapist-rated alli-
ance increased in both groups. Furthermore, stronger therapist-rated alliance 
predicted lower symptomatic distress in the same timepoint in MOTR+GPM-
BV but not GPM-BV. In addition, only in MOTR+GPM-BV did lower symp-
tomatic distress predict subsequent stronger therapist-rated alliance, but not 
the other way around.
When examining agreement and congruence in alliance ratings, we 
found that in GPM-BV therapists’ ratings of the alliance were lower than pa-
FIGURE 2. Symptom severity as a function of therapist- and patient-
rated alliance during Good Psychiatric Management, brief-version 
(GPM-BV; top panels) and GPM combined with Motive-Oriented 
Therapeutic Relationship techniques (MOTR+GPM-BV; bottom pan-
els) at the session- (left panels) and patient-levels (right panels).
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tients’ ratings, while in MOTR+GPM-BV this disagreement was mitigated. 
Importantly, higher agreement predicted lower symptomatic distress in the 
same timepoint in MOTR+GPM-BV but not in GPM-BV. Congruence over 
time between patient- and therapist-rated alliance existed in both groups, but 
was not related to outcome.
CHANGE IN ALLIANCE DURING THERAPY
Across treatments and raters, we found that the alliance tended to be weak-
moderate at baseline, which is consistent with clinical writings on difficul-
ties in forming a strong alliance with BPD patients (Gabbard et al., 1988). 
However, we also found that patient- and therapist-rated alliance tended 
to increase during MOTR+GPM-BV, while only therapist-rated alliance in-
creased during GPM-BV. This suggests that despite the difficulties, it is pos-
sible to strengthen the alliance with BPD patients, even in short-term treat-
ments. This also suggests that individualizing treatment to the relationship 
needs of the patient results in a stronger alliance on the part of the patient. 
The fact that our analyses resulted in different results from those reported 
by Kramer, Kolly, et al. (2014) could be attributed to the high percentage of 
missing alliance data, especially patient-rated alliance data (188 missing pa-
tient-rated observations vs. 149 missing therapist-rated observations). This 
finding emphasizes the importance of utilizing imputation methods when 
appropriate (Enders et al., 2016).
In terms of outcome prediction, consistent with the existing literature 
(reviewed in Zilcha-Mano, 2017), we found that session-level changes in 
the alliance were predictive of outcome in MOTR+GPM-BV but not in 
GPM-BV. These findings suggest that the alliance is a dynamic construct that 
evolves during therapy, and that these dynamics are especially predictive of 
outcome. In addition, the stronger prediction found in MOTR+GPM-BV 
emphasizes the important role that the alliance may play in individualized 
and relationship-based psychotherapies, and it may suggest a specific media-
tion that occurs in that group. Thus, consistent with other approaches to 
training therapists in strengthening the alliance (Crits-Christoph et al., 2006; 
Eubanks-Carter, Muran, & Safran, 2015), our findings suggest that tailoring 
the therapeutic relationship to the individual patient mitigates the attenua-
tion of the alliance–outcome correlation that has been observed in psycho-
therapies for BPD (Levy et al., 2017). However, it should be noted that in 
contrast to some other studies (reviewed in Zilcha-Mano, 2017), the alliance 
did not predict outcome in a lag, but rather the opposite: In MOTR+GPM-
BV, better outcome predicted stronger alliance in a lag. Thus, although some-
thing about the additional component of MOTR caused therapist-rated alli-
ance to be correlated with outcome, it seems like changes in outcome precede 
changes in alliance and not the other way around. However, the short dura-
tion of the treatments described here does not allow us to arrive at conclu-
sions regarding the longer treatment durations that are more typical for pa-
tients with BPD. For example, it could still be that early in therapy, changes 
in alliance follow symptom change, and only in later phases, when changes 
in interpersonal difficulties occur, does the alliance begin to drive symptom 
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change (cf. Zilcha-Mano, 2017). Thus, these possible explanations should 
be further examined in long-term treatments in order to fully understand 
the temporal unfolding of the alliance–outcome correlation in this specific 
population.
AGREEMENT AND CONGRUENCE IN ALLIANCE SCORES
We found that therapist-rated alliance was lower than patient-rated alliance 
in GPM-BV, which is consistent with other published studies on the topic 
(Atzil-Slonim et al., 2015; Compare et al., 2016; Zilcha-Mano et al., 2017). 
The lower therapist- compared to patient-rated alliance is also consistent 
with a meta-analysis of cross-sectional studies that reported that the dif-
ference between patient- and therapist-rated alliance tended to be higher in 
studies of severely disturbed patients, including patients with BPD (Tryon et 
al., 2007). However, the addition of MOTR eliminated this disagreement, 
which suggests that individualizing the therapeutic relationship for the needs 
of the patient decreases disagreement between the patient’s and the thera-
pist’s experience of the therapeutic alliance. Importantly, in MOTR+GPM-
BV (but not in GPM-BV), symptomatic distress tended to be lower in time-
points in which patient and therapist agreed that the alliance is strong. This 
finding adds to the existing findings about other potential mediators of the 
effect of MOTR+GPM-BV (i.e., change in behavioral coping; Kramer et al., 
2017) and suggests that MOTR+GPM-BV exerts its effects partly by increas-
ing agreement. Importantly, to our knowledge, the current study is the first 
to decompose session- and patient-level contributions of agreement to the 
prediction of symptomatic distress. The fact that only session-level, but not 
patient-level, agreement tended to predict lower symptomatic distress speaks 
to the importance of examining the dynamics of the alliance, rather than 
viewing it as a stable patient characteristic. However, the effect was margin-
ally significant and the actual temporal order of it is still unknown, so more 
research is needed before conclusions can be reached.
We found a significant temporal congruence between patient- and ther-
apist-rated alliance in both treatments. This means that therapists’ and pa-
tients’ ratings tended to covary together over time, such that therapists and 
patients showed similar fluctuations in alliance throughout treatment. This 
finding is consistent with the findings of Atzil-Slonim et al. (2015) but not 
Compare et al. (2016). Given that Compare et al. (2016) examined group 
psychotherapies, it is possible that the alliance to multiple group members 
makes it difficult for therapists to reach congruence with the alliance of a 
specific patient. However, in contrast to Atzil-Slonim et al. (2015), in our 
study congruence did not predict outcome, which may suggest that, at least 
with BPD patients, agreement (lower mean differences) is more important 
than temporal congruence.
STUDY LIMITATIONS
One of the strengths of the present study is the inclusion of both patient- and 
therapist-rated measures of the alliance. However, including an observer-
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rated measure of the alliance could have complemented our findings as well 
as allowing for a more objective evaluation of the alliance. Related to that, 
the outcome measures in the study included only patient reports, and not 
therapist- or clinician-rated measures. Therapist-rated measures of symp-
tomatic distress would have enabled us to perform a full two-person perspec-
tive analysis examining the independent and interactive effects of both raters 
(Zilcha-Mano et al., 2016).
Another limitation to consider is the relatively short duration of the psy-
chotherapies used in the study (10 sessions). The length of treatment prevent-
ed us from examining the unfolding of the alliance during a longer period of 
time, although studies do show that the alliance predicts outcome, irrespec-
tive of when it is assessed (Horvath et al., 2011). 
Last, the moderate sample size is another limitation that has likely un-
derpowered some of our analyses. This is especially true regarding group-lev-
el comparisons, in which our analyses were mostly powered to detect large 
effects, and regarding analyses involving the OQ-45, which was measured in 
only three timepoints.
CLINICAL AND RESEARCH IMPLICATIONS AND CONCLUDING 
COMMENTS
Clinically, our findings point to the potential benefits of individualizing the 
therapeutic relationship to match the specific needs of the patient. In ad-
dition, as more similar findings accrue, the findings may also suggest the 
importance of monitoring patient and therapist alliance and examining pos-
sible sources of discrepancy between the two.
In terms of research implications, the study demonstrates the importance 
of studying the dynamics of the alliance in a nuanced way, including ses-
sion-level alliance as well as agreement and congruence between patient- and 
therapist-reports. Special attention should be given to cross-lagged effects 
that may shed light on the causal direction between alliance and outcome, 
as well as the appropriate time lag of these associations. These cutting-edge 
examinations require more intensive data collection than is typically done in 
psychotherapy research, as well as collection of alliance and outcome mea-
sures from multiple raters (e.g., patient and therapist).
In conclusion, our study examined the effect of adding an ingredient of 
alliance individualization to a brief -treatment of patients with BPD, a severe, 
difficult-to-treat population. The findings show that such individualization 
does not necessarily result in stronger patient-rated alliance, but rather in 
higher agreement between patients’ and therapists’ experience of the alliance 
and in stronger ties with outcome. Thus, individualizing psychotherapy may 
exert part of its salutary effect by increasing the agreement between patients 
and therapists.
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APPENDIX: MODELS FITTED IN THE CURRENT STUDY
CHANGES IN ALLIANCE DURING TREATMENT
Level-1 Model: 
Level-2 Model:
Where WAI = Working Alliance Inventory–Short Form, Therapist/Patient ver-
sion; Session_number = session number in therapy, centered around the first ses-
sion; Group = GPM-BV/MOTR+GPM-BV.
PATIENT- AND SESSION-LEVEL ALLIANCE AS PREDICTORS OF 
SYMPTOMATIC DISTRESS
Level-1 Model:
Level-2 Model:
Where OQ-45  = Outcome Questionnaire–45.2; WAI = Working Alliance Inven-
tory–Short Form, Therapist/Patient version; Group = GPM-BV/MOTR+GPM-BV.
20 KIVITY ET AL.
TRUTH AND BIAS MODEL OF ALLIANCE RATINGS
Level-1 Model:
Level-2 Model:
Where WAI-T  = Working Alliance Inventory–Short Form, Therapist version; WAI-
P = Working Alliance Inventory–Short Form, Patient version; Group = GPM-BV/
MOTR+GPM-BV.
MULTILEVEL POLYNOMIAL REGRESSION (SEPARATE MODELS WERE 
FITTED FOR EACH GROUP)
Level-1 Model:
Level-2 Model:
Where OQ-45 = Outcome Questionnaire–45.2; WAI-T = Working Alliance Inven-
tory–Short Form, Therapist version, centered to scale midpoint; WAI-P = Working 
Alliance Inventory–Short Form, Patient version, centered to scale midpoint.
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PATIENT-LEVEL TEMPORAL CONGRUENCE AS A PREDICTOR OF 
SYMPTOMATIC DISTRESS
Level-1 Model:
Level-2 Model:
Where OQ-45 = Outcome Questionnaire–45.2; Congruence = Person-specific cor-
relation between therapist- and patient-rated alliance across sessions, Fisher’s z 
transformed; Group = GPM-BV/MOTR+GPM-BV.
